Trial Profile
Non-interventional study on the safety and efficacy of an Abraxane(R) mono therapy for the therapy of patients with metasasized breast cancer with special consideration of the toxicity profiles.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms Abraham
- 06 Jul 2012 Actual initiation date (1 Sep 2011) added as reported by German Clinical Trials Register record.
- 06 Sep 2011 New trial record